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Abbreviations 
21OH 21-hydroxylase, used as positive FLAG control 
AIRE Autoimmune regulator, a transcriptional regulator 
APECED Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy, an alternative name for APS-1 
APS-1 Autoimmune polyendocrine syndrome type 1 
ARMC5 Armadillo Repeat-Containing Protein 5 
Brd4 Bromodomain-containing protein 4, transcriptional inhibitor 
BSA Bovine serum albumin, albumin protein extract 
C311Y AIRE variant with the C311Y mutation, a dominant missense mutation 
CARD Caspase recruitment domain, a protein interaction domain 
CBP CREB-binding protein, a transcriptional activator 
CCNH Cyclin H 
CD Cluster of differentiation, surface molecule or protein used to differentiate between cell types 
cDNA Complementary DNA, DNA reverse transcribed from mRNA, lacks introns 
CHAC1 ChaC Glutathione Specific Gamma-Glutamylcyclotransferase 1 
CNS1 Conserved non-coding sequence 1, an enhancer sequence 
CTCF CCCTC-Binding Factor, a transcriptional inhibitor 
Ctcfl CCCTC-Binding Factor Like, a transcriptional enhancer, works by replacing CTCF 
cTEC Cortical thymic epithelial cells 
DN Double negative T-Cells, does not have the surface markers CD4 or CD8 
DP Double positive T-Cells, has both the surface markers CD4 and CD8 
ERMAP Erythroblast Membrane Associated Protein 
FACS Fluorescence-activated cell sorting, cell sorting method using flow-cytometry 
FC Fold change, a number describing the change in quantity between two states in a comparison 
FLAG Protein tag with the DYKDDDDK sequence 
GAPDH Glyceraldehyde-3-Phosphate Dehydrogenase  
GOrilla Gene Ontology enRIchment anaLysis and visuaLizAtion, a gene ontology enrichment tool 
GRCh38 Genome Reference Consortium Human Build 38, reference genome 
H3K27ac Acetylated Lysine 27 on the histone tail of histone H3 
H3K4me0 Unmethylated Lysine 4 on the histone tail of histone H3 
H3K4me1 Mono-methylated Lysine 4 on the histone tail of histone H3 
H3K4me3 Tri-methylated Lysine 4 on the histone tail of histone H3 
Hnrnpl Heterogeneous Nuclear Ribonucleoprotein L, a transporter of P-TEFb 
HSR Homogenously staining region, the previous name for the CARD domain in AIRE 
IGFL1 Insulin Growth Factor-Like Family Member 1 
IL10RA Interleukin 10 Receptor Subunit Alpha  
INHBE Inhibin Beta E Subunit 
Irf4 Interferon Regulatory Factor 4, a transcriptional regulator 
Irf8 Interferon Regulatory Factor 8, a transcriptional regulator 
JMJD6 Arginine Demethylase and Lysine Hydroxylase, a pre-mRNA splicing factor 
KRT14 Keratin 14 
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LDS-PAGE Lithium dodecyl sulphate polyacrylamide gel electrophoresis, a protein electrophoresis method 
MHC Major histocompatibility complex, antigen presenting, also known as HLA 
MITE Mutagenesis by integrative tiles, a multiplexed controlled mutagenesis method 
mTEC Medullary thymic epithelial cells 
Myc Protein tag with the EQKLISEEDL sequence 
NFκB  Nuclear Factor κB, a signalling complex 
NHEJ Non-homologous end joining, a DNA repair pathway 
NLS Nuclear localisation sequence, a peptide sequence in a protein necessary for nucleus entry 
NMD Nonsense mediated decay, an RNA degradation pathway triggered by premature stop codons 
P300 E1A binding protein, a transcriptional coactivator 
padj FDR adjusted p-value, or Benjamini-Hochberg (BH) adjusted p-value 
PBS Phosphate buffered saline, a buffer solution 
PHD Plant homeodomain, a zinc finger structure 
PTA Peripheral tissue antigens 
P-TEFb Positive Transcription Elongation Factor b, protein kinase and transcriptional activator 
PTH Parathyroid hormone 
PVDF A polyvinylidene difluoride membrane 
qPCR Quantitative polymerase chain reaction, gene expression analysis method, also known as Real-Time PCR 
R257X AIRE variant with the R257X mutation, recessive nonsense mutation 
RANK Receptor Activator of Nuclear Factor κB, member of the TNF family 
RANKL Receptor Activator of Nuclear Factor κB ligand 
RelA the NFκB subunit p65 
RIN RNA integrity number, a measure of RNA quality, a number between 1-10 where 10 is the highest quality 
RNAseq RNA sequencing, a method for transcriptome analysis 
rRNA Ribosomal RNA, RNA used directly in ribosomal structures necessary for protein synthesis 
S100A8 S100 Calcium Binding Protein A8  
SAND DNA recognition domain, named for the proteins: Sp100, AIRE, NucP41/75, and DEAF-1 
SLC3A2 Solute Carrier Family 3 Member 2 
SLC7A11 Solute Carrier Family 7 Member 11 
SP Single positive T-cells, has either CD4 or CD8 
TBS Tris buffered saline, a buffer 
TBS-T A TBS buffer with added Tween20 
Tbx21 T-Box 21, a transcriptional regulator 
Tcf7 Transcription factor 7, a transcriptional regulator 
TCR T-cell receptor, antigen sensing 
TNF Tumour necrosis factor, a transmembrane cell signalling protein family 
TOP1 Topoisomerase I, responsible for single stranded breaks in DNA 
TOP2 Topoisomerase II, part of the NHEJ DNA repair pathway, responsible for double stranded breaks in DNA 
TPM Transcripts per million, absolute expression value normalised against gene length and sequencing depth 
TRA Tissue-restricted self-antigens 
Tregs Regulatory T-cells, positive for CD4, CD25 and FOXP3 
TSA Tissue-specific antigens 
UPR Unfolded protein response, a cell response to misfolded proteins 
Wt Wildtype, the predominant gene variant 
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Summary  
The autoimmune regulator protein, known as AIRE, is a potent transcriptional regulator 
active in medullary thymic epithelial cells (mTECs) of the thymus, where it is able to switch 
on the expression of thousands of genes commonly only expressed in specialised peripheral 
tissues. This ability of AIRE makes it a crucial component in the immune system, specifically 
for the process of negative selection, in which T-cells are evaluated in their ability to 
recognise the body’s own proteins. This works as a check-point to avoid autoimmunity, and 
T-cells that bind to AIRE induced proteins are terminated as they are considered dangerous 
for the organism. Disruption of AIRE function by mutations leads to the disease autoimmune 
polyendocrine syndrome type 1 (APS-1), in which autoimmune T-cells initiate destructive 
processes affecting a variety of functions in the body. Clinically, APS-1 is defined as the 
presence of at least two out of three major manifestations: Addison’s disease (adrenal 
insufficiency), hypoparathyroidism and chronic mucocutaneous candidosis. However, 
patients may not necessarily present the major manifestations, and may also exhibit a variety 
of other manifestations, both of which may be related to the severity of the underlying 
mutation. 
AIRE consists of a number of functional domains; a CARD sequence used for AIRE 
dimerisation, a SAND domain for general DNA interaction, and two PHD zinc fingers, one 
used for histone interaction, and the other for protein recruitment and interaction. AIRE 
induction works in a stochastic manner, targeting genes that are passively downregulated by 
methylated histone marks, or that are otherwise actively repressed. Therefore AIRE induced 
genes differ between cells because of the sheer amount of inducible genes, as well as 
between different cell types, because different cell types will repress different genes. 
In order to study AIRE function and inform larger sequencing and GWAS studies, we are 
aiming to develop a functional screening assay for AIRE mutations, using a deep mutational 
scanning approach. This would attempt to characterise the functional effect of any 
hypothetical mutation within AIRE and would require a robust reporter gene. This would be 
a gene with high expression in AIRE wildtype, but low expression in an AIRE mutant, while 
preferably encoding a cell surface protein for easier FACS sorting. To identify these reporter 
genes we aimed to develop a robust cell system with AIRE. This cell system needed to be 
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amenable to large-scale transfection and FACS sorting, and be robustly expressing functional 
AIRE proteins. We, therefore, investigated the expression of known AIRE reporter genes, 
curated from the literature, and evaluated the usability of these genes as possible reporters. 
Furthermore, we developed a protocol for AIRE inducible gene discovery using RNA 
sequencing and evaluated different methodological approaches to this.  
We successfully established a robust cell system based on AIRE transfected HEK293FT cells, 
which exhibited substantial AIRE expression. By using qPCR probes for known AIRE induced 
genes, we also confirmed that AIRE was functionally active.  
We found that the previously reported AIRE regulated genes KRT14 and S100A8 could be 
used as reporter genes based on lower expression in selected AIRE mutants.  We found that 
RNAseq is highly consistent between experiments and across methodological approaches 
when it comes to library preparation, and correlates well with results using qPCR. However, 
we were unable to identify new reporter genes fitting our criteria, and the reporter gene 
candidates KRT14 and S100A8 were too weakly expressed to be detected by RNAseq. 
Comparing the AIRE wildtype with untransfected cells yielded substantial transcriptome 
differences, consistent with the literature, yet did not yield usable reporter genes. Comparing 
the AIRE mutants R257X and C311Y with the wildtype, in order to find downregulated genes 
in the mutants, we found a large population of upregulated genes in the R257X mutant and 
little difference between C311Y and wildtype. Neither of these mutants has previously been 
investigated using transcriptome analysis, and so it is uncertain how representative these 
results are, but they are consistent across our experiments. Western blot analysis showed 
some degradation in all transfected populations, yet substantial degradation of the C311Y 
mutant, suggesting a possible instability in this variant. 
AIRE is a fascinating transcriptional regulator able to induce the expression of repressed 
genes, but the knowledge of AIRE and its function is still incomplete. The failure of our 
RNAseq approach to detect AIRE reporter genes indicates that changes in methodology are 
required. Such changes may still render a deep mutational scanning approach a viable option 
for the purpose of studying AIRE. 
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1. Introduction 
AIRE or the Autoimmune Regulator is a gene located on the long arm of chromosome 21 
(21q22.3) that encodes a protein that is 545 amino acids long and 57.7 kDa in size.1, 2, 3 AIRE 
works as a transcriptional regulator, and is able to induce the expression of thousands of 
genes coding for proteins known as tissue-restricted self-antigens (TRA), tissue-specific 
antigens (TSA), or peripheral tissue antigens (PTA).4 These are proteins that are usually 
expressed only in particular tissues. This ability of AIRE makes it a crucial part of the negative 
selection of T-cells in the thymus as part of the process known as central tolerance.5 
Mutations in AIRE may disrupt this process, leading to the development of the disease 
autoimmune polyendocrine syndrome type 1 (APS-1).  
AIRE expression 
Because of AIRE’s ability to induce expression of such a broad spectrum of proteins, it is 
crucial that its expression is tightly controlled. AIRE is predominantly expressed in a subset 
of thymus cells called medullary thymic epithelial cells (mTEC), although a few B-cells, a few 
cells in the spleen and lymph nodes, and testicular germ cells are also able to express AIRE.6 
While AIRE is expressed principally in mTEC, it is confined to a mTEC population characterised 
by high MHC class II expression on its surface in addition to expression of the cluster of 
differentiation (CD) costimulatory proteins CD80 and CD86.7, 8 Expression of these proteins 
in addition to the numerous TRA induced by AIRE expression make these mTECHi cells 
excellent self-antigen presenting cells. In mTEC AIRE localises to the nucleus where it 
multimerises and forms nuclear bodies, structures composed of chromatin and protein in the 
nucleus, also known as nuclear dots, and in the cytoplasm where it co-localises with 
cytoskeletal filaments.9, 10, 11 In order to be restricted to such a small number of cells, AIRE 
expression is controlled in a variety of ways, some of which have been delineated. In mTEC 
H3K4me3 methylation of the histones in the promoter area of AIRE relaxes the chromatin 
structure and allows access to the promoter sequence.12 In addition, a signalling pathway 
necessary for AIRE expression is the tumour necrosis factor (TNF) receptor family member 
Receptor Activator of Nuclear Factor κB (RANK) signalling pathway.8 RANK Ligand (RANKL) on 
the surface of other thymic cells activate RANK signalling in a few mTEC, which leads to the 
activation of the canonical NFκB signalling pathway. The release of the NFκB signalling 
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complex allows movement of this complex consisting of the NFκB subunits p65 (RelA) and 
p50 into the nucleus where it binds to the CNS1 enhancer sequence located around 3kbp 
upstream of AIRE and which contains two 10bp RelA binding motifs.13 There is also evidence 
of efficient AIRE expression being dependent on a complex of the transcriptional regulators 
Interferon Regulatory Factor 4 (Irf4), Interferon Regulatory Factor 8 (Irf8), T-Box 21 (Tbx21), 
and Transcription Factor 7 (Tcf7), in addition to the replacement of the inhibitor CCCTC-
Binding Factor (CTCF) with CCCTC-Binding Factor Like (Ctcfl).14 Another control of AIRE 
concerns the proper splicing of the AIRE pre-mRNA, where the splicing regulator Arginine 
Demethylase And Lysine Hydroxylase (JMJD6) is necessary for the proper splicing of AIRE.15 
Thus, if JMJD6 is not present the AIRE mRNA will retain intron 2 with a premature stop codon 
leading to activation of the nonsense mediated decay (NMD) pathway, and degradation of 
the mRNA before translation.  
AIRE protein 
The protein structure of AIRE is composed of a series of protein domains (Fig. 116, 17), as well 
as other motifs of known function. These consist of a Caspase recruitment domain (CARD), a 
SAND domain (named for the proteins Sp100, AIRE, NucP41/75, and DEAF-1), two plant 
homeodomain (PHD) zinc fingers, a Nuclear Localisation Sequence (NLS), and four LXXLL 
sequences.18, 19, 20 The CARD, previously known in AIRE as the homogeneously staining region 
(HSR), is important for AIRE oligomerisation.20, 21 In addition, posttranslational modification 
of the CARD sequence has been linked to interaction with the inhibitor Bromodomain-
containing protein 4 (Brd4) attracting the Positive Transcription Elongation Factor (P-TEFb) 
that is needed for successful transcription of AIRE regulated genes.22 The SAND domain is a 
well-conserved ~80 amino acid sequence found in a range of DNA interacting nuclear 
proteins.19 The DNA binding properties of the SAND domain are thought to be linked to a 
positively charged surface patch containing the conserved amino acid sequence KDWK; 
however, AIRE’s SAND domain instead contains the modified amino acid sequence NKAR. 
Also, AIRE does not have the Zinc-binding sequence that is present in other SAND domains.23 
The AIRE sequence consists of PHD zinc fingers; however, it is likely that these two PHD 
domains have different functions within AIRE.24 PHD1 has been linked to interaction with the 
tail of histone H3 (Fig. 2), specifically H3K4 when this lysine is unmethylated (H3K4me0).25, 26, 
27   
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Figure 1 Estimated structure and overview of the AIRE protein with its functional domains. AIRE structure 
model estimated from homologous sequences using Phyre216 (64% of residues with >90% confidence). Model 
annotated and rendered in PyMOL17. CARD domain in red, Nuclear localisation sequence (NLS) in green, SAND 
domain in blue, and two PHD zinc fingers in yellow. Overview created with Scribus. 
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Trimethylation of lysine 4 of histone 
H3 (H3K4me3) is characteristic of 
transcriptional activation, and so 
PHD1 recognition of a nonmethylated 
H3K4 is indicative of PHD1 interaction 
with inactive genes.28 While the 
surface of PHD1 is negatively charged, 
facilitating interaction with the 
positively charged histone tail, the 
PHD2 surface is positively charged, 
indicating that PHD2 is not involved in 
histone interactions.29 Instead, mounting evidence supports the importance of the PHD2 
domain in AIRE partner interaction.24, 29 Deletion of the PHD2 domain has been shown to 
stop AIRE interaction with known partners with functions related to transcription, chromatin 
binding and nuclear transport.24 The NLS is a signal required for the proper transport of large 
proteins from the cytosol to the nucleus through the nuclear pore complex.30 The NLS in AIRE 
is characterised as a monopartite NLS that allows AIRE to be transported after interaction 
with the adaptor protein importin α.31 AIRE also contains four distinct sequences with the 
amino acid pattern LXXLL, which are known nuclear receptor interaction domains.32 
AIRE protein interactions 
AIRE interacts with a variety of proteins, with the majority of its functional domains. AIRE’s 
nuclear receptor interaction domains may attract CREB-binding protein (CBP) and the E1A 
binding protein p300 (P300), which has been found to induce acetylation of AIRE, reducing 
transcription of AIRE target genes.18, 33 This process can be reversed by the deacetylase 
Sirtuin-1 which seems to counteract the CBP/P300 inhibition of AIRE, and thus be necessary 
for AIRE activity.34 While AIRE has been found to target inactive genes marked by H3K4me0, 
AIRE also interacts with the repressive complex ATF7ip-MBD1, thereby targeting genes 
actively repressed in the cell.35 There are many other AIRE interacting proteins important in 
AIRE target gene transcription, consistent with AIRE interaction in large multimeric protein 
complexes, and these can be categorised (Fig. 3) into proteins that are linked to transcription, 
pre-mRNA processing, chromatin binding and structure, and nuclear transport.24, 36 After 
Figure 2 3D representation of NMR structure of AIRE 
PHD1-Histone H3 interaction. Cartoon 
representation in a, surface representation in b, 
histone sequence in yellow. Surface charge in b 
visualised as negative in red and positive in blue. 
Image reproduced in part from Chakravarty et. al. 
2009 with permission.27 
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AIRE is recruited to inactive or 
repressed genes marked by H3K4me0 
or ATF7ip-MBD1, AIRE is found to 
migrate over and to co-localise to 
super-enhancers.37 Super-enhancers 
are long chromatin sections marked 
with H3K27ac and H3K4me1 histone 
marks that hosts a high number of 
transcription factors. These sections 
are possibly working as depots for 
efficient transcription, looping 
around to active transcription sites to 
interact with RNA polymerase II and 
its preinitiation complex. One of the 
proteins associated with super-
enhancers is the protein Brd4 which 
binds to AIRE.37 Brd4 binding leads to 
recruitment of the positive transcription elongation factor P-TEFb, which is transported to 
AIRE by the Heterogeneous Nuclear Ribonucleoprotein L (Hnrnpl). 22, 38, 39, 40 P-TEFb is a 
transcriptional elongation factor that works by phosphorylating stalled RNA-polymerase II, 
thereby releasing it to continue gene transcription of AIRE target genes.41, 42 In addition to 
inducing gene transcription, AIRE association to super-enhancer regions leads to interaction 
of AIRE with the DNA topoisomerase TOP1.37 TOP1 introduces single-strand nicks in the DNA, 
where only one of the DNA strands are cut, and it is possible that these nicks recruit the non-
homologues end joining (NHEJ) DNA repair complex DNA-PK, consisting of the protein kinase 
DNA-PKcs, the Ku80 -Ku70 heterodimer, PARP-1, FACT, and the topoisomerase TOP2. While 
it is unclear exactly how this complex works together with AIRE, it does introduce single nicks 
(TOP1) or double-stranded breaks (TOP2) that relaxes the chromatin structure allowing for 
efficient transcription. Furthermore, it is possible that this works as a histone eviction 
complex that removes histones in front of the transcribing RNA polymerase II, keeping the 
transcription complex from slowing down.37 In addition to initiating and ensuring efficient 
transcription of AIRE target genes, other partners are important in the efficient processing of 
Figure 3 Overview of some AIRE interacting proteins 
categorised into functional groups. Image taken from 
Yang et. al. 2013.24  
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the resulting pre-mRNA. AIRE interacts with a variety of these genes (Fig. 3) exemplified by 
the small nuclear ribonucleoprotein EFTUD2, that has been shown to localise to AIRE 
containing nuclear bodies.43 This pre-mRNA processing complex ensures that the pre-mRNA 
is spliced into mRNA as fast as possible, consistent with the fact that AIRE greatly increases 
the mRNA levels of its target genes, yet the pre-mRNA levels of those same genes remain 
low.43 In addition, the mRNA processing might affect the stability of the transcripts, as the 
AIRE induced genes have a relatively long half-life compared to other genes. 
AIRE induced gene expression 
AIRE is responsible for the promiscuous expression of TRA in mTEC of the thymus, giving a 
very small subset of cells in the thymus one of the broadest gene expression profiles of any 
cell.44, 45, 46, 47 These TRA genes are usually specific to distinct tissues, and have a low 
expression in mTEC when AIRE is inactive.48 Of the up to 19,293 protein-coding genes 
expressed in AIRE positive mTEC, AIRE induction is responsible for increased expression of up 
to 3980.47 Interestingly, overrepresented among the genes not induced in these cells are the 
functional gene ontology categories of the olfactory and vomeronasal receptors. The 
expression profile of mTEC, consisting of induced and repressed genes, is not dependent 
solely on AIRE, as the introduction of AIRE into cells and cell systems other than mTEC results 
in different AIRE induced expression profiles.48, 49 This is consistent with the way AIRE targets 
inactive, or actively repressed genes, genes that will necessarily differ between cell types.26, 
35, 48 Single cell studies of individual mTEC show that the AIRE induced gene expression differs 
significantly from cell to cell, in a stochastic manner, meaning that each cell will have 
different gene expression from each other, with no single cell able to express the full AIRE 
induced transcriptome.50 However, the gene expression in a single cell is not entirely 
stochastic, as genes located close to each other in the genome have a higher chance of being 
expressed together.51 The expression of AIRE induced genes while high in each single cell, are 




The expression of TRA by the function of AIRE is crucial to the process of central tolerance of 
thymocytes (developing T-cells) in the adaptive immune system. Central tolerance is the 
process in which the developing lymphocytes are checked for their ability to bind to the 
body’s own proteins, called self-antigens.52 The mammalian immune system is divided into 
two different systems, the passive fast acting innate immune system, and the active slower 
acting adaptive immune system. The adaptive immune system requires the rearrangement 
of the genes encoding B- and T-cell receptors in order for the adaptive immune system to 
recognise unknown pathogens and foreign molecules. However, this extraordinary ability 
means that a few of these rearrangements might lead to autoimmune cells that recognise 
the body’s own proteins. These cells must, therefore, be identified and eliminated in order 
to ensure no autoimmune 
diseases arise. Both 
developing B-cells and T-cells 
must undergo central 
tolerance; however, while B-
cells undergo this process in 
the bone marrow, immature 
T-cells are transported to the 
thymus. Immature T-cells 
undergo a variety of tests in 
the thymus, where they move 
gradually from the outer 
cortex into the medulla (Fig. 
4).53 After entering the thymic 
cortex through blood vessels 
from the bone marrow, 
immature thymocytes are 
double negative (DN) for the 
molecules CD4 and CD8. In 
their journey through the cortex, these cells go through multiple stages (DN1-4) in which 
their T-cell receptors (TCR) are rearranged, and they end up expressing both the CD4 and 
Figure 4 The path taken by an immature thymocyte through 
the thymus. Immature thymocytes from the bone marrow enter 
the cortex through blood vessels, then mature from CD8/CD4 
double negative (DN) to double positive (DP) T-cells. The double 
positive T-cells get checked for their ability to bind MHC 
molecules in positive selection by cTEC, then their inability to 
bind the body’s own proteins in negative selection by AIRE 
expressing mTEC. Image reproduced from Klein et. al (2009) 
with permission.53 
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CD8 molecules as double positive (DP) T-cells. First, these thymocytes are checked for their 
ability to present TCR on their surface, signifying a successful receptor rearrangement. 
Secondly, the thymocytes undergo the process of positive T-cell selection, in which their 
ability to bind to and recognise the antigen presenting major histocompatibility complex 
(MHC) class I or II receptors on the surface of antigen-presenting cells are checked by binding 
MHC molecules on the surface of cortical thymic epithelial cells (cTEC). The majority of 
thymocytes are eliminated in this step, where they die by neglect after not receiving certain 
survival signals. In the process of positive selection, surviving cells also differentiate into 
single positive (SP) T-cells by becoming either CD4 positive T-helper cells or CD8 positive 
cytotoxic T-cells depending on increased binding affinity to MHC class II and I respectively. 
Finally, if the thymocytes survive the positive T-cell selection, they migrate into the medulla 
of the thymus where they undergo the process of negative T-cell selection. This process is 
where AIRE is a crucial component, and consists of checking the thymocytes in their ability 
to bind MHC receptors presenting peptides from the body’s own TRA on the surface of mTEC. 
T-cells that bind too strongly to the MHC presenting a self-peptide undergo apoptotic 
deletion, or gets turned into the immunosuppressive CD4, FOXP3 and CD25 positive 
regulatory T-cells (Tregs)54, while the T-cells with a low or intermediate affinity for the 
MHC/TRA complex are allowed to migrate out of the thymus into peripheral tissues.  
APS-1 
Mutations in AIRE leading to a failure of negative T-cell selection is the cause of the 
autoimmune disorder APS-1 also known as autoimmune polyendocrinopathy candidiasis 
ectodermal dystrophy (APECED).2 APS-1 (OMIM 240300) is a monogenic disease, with 
predominantly autosomal recessive inheritance, although dominant forms have also been 
reported.55, 56, 57 The prevalence of APS-1 is estimated to be 1:100 000 on a worldwide basis, 
while the prevalence in Norway is around 1:90 000. The prevalence peaks in certain 
populations such as amongst Persian Jews (1:9 000), Sardinians (1:14 000) or Finns (1:25 
000).58, 59 APS-1 is characterised by the three major manifestations of Addison’s disease, 
hypoparathyroidism and chronic mucocutaneous candidosis, although other symptoms vary 
significantly amongst patients.60 Addison’s disease is caused by low or absent production of 
the steroid hormones cortisol and aldosterone, causing patients to become fatigued, causing 
the skin to darken, leading to weight loss, and the desire to consume salt.59 
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Hypoparathyroidism is defined by low production of parathyroid hormone (PTH), low calcium 
but high phosphate in the blood, leading to muscle cramps, grand mal seizures and 
clumsiness.59 Finally, chronic mucocutaneous candidosis is chronic infection with the yeast 
Candida albicans typically as an infection of the mouth, but it can also spread to the throat, 
intestines and fingernails.59 Symptoms include soreness of the corner of the mouth, 
problems in consuming acidic or spicy food, trouble swallowing if the infection spreads to 
the throat, abdominal pain, diarrhoea and flatulence if it spreads to the intestines. Candidosis 
is usually the first symptom to appear, followed by hypoparathyroidism and then Addison’s 
disease, although not all patients will contract all three disease aspects.59, 61 Addison’s 
disease and hypoparathyroidism can both prove fatal if not diagnosed and treated in time, 
such treatment mainly consisting of hormone replacement therapy. Disease onset is usually 
during childhood and adolescence, though milder dominant forms may have a later onset.57, 
59 Other common manifestations are type-1 diabetes mellitus, ovarian insufficiency, enamel 
hypoplasia (deficient enamel of the teeth), alopecia (loss of hair), keratitis (inflammation of 
the eye), and vitiligo (loss of pigment in the skin).59, 62  
AIRE mutations 
Over 100 mutations in AIRE have been reported to cause APS-1 (www.hgmd.cf.ac.uk), with 
the major Finnish mutation R257X and the 13 base-pair deletion C322del13 being the most 
prevalent. R257X is a recessive nonsense mutation changing from an arginine to a premature 
stop codon within the SAND domain, leading to a loss of both PHD zinc fingers (Fig. 5).63 The 
13 base pair deletion is located within the first PHD zinc finger, disrupting it and introducing 
a premature stop codon leading to a truncated protein without the second PHD zinc finger.63 
Some examples of rare AIRE mutations are the dominant negative mutation C311Y, leading 
to a disruption of the zinc-binding structure of the first PHD zinc finger, and the splice 
mutation c.879+1G>A, causing a truncation of the SAND domain.57, 58 AIRE mutations found 
Figure 5 Overview of the AIRE protein with its functional domains and some known mutations. 
Mutations shown are the recessive R257X major Finnish mutation, the exon skipping 879+1G>A, the 
dominant C311Y, and the 13 base-pair deletion C322del13. Graphic created with Scribus. 
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in patients are spread throughout the gene sequence, although the majority of them are 
located within the CARD, and the two PHD zinc-finger sequences.64 Curiously, most dominant 
mutations have so far been located in exon 8, at the start of the first PHD domain. 
Deep mutational scanning assay 
While the traditional way to discover disease-causing mutations is by sequencing of affected 
patients after clinical diagnosis has been suspected or confirmed, new techniques make it 
possible to investigate the negative aspects of any possible mutation in vitro. Using a 
technique called deep mutational scanning, a library of gene variants can be synthesised, 
transfected into a cell population, which is then screened for functional effect and sequenced 
(Fig. 6).65, 66 The first step of this process is the creation of a library of gene variants containing 
single base substitutions for any locus in the gene using saturation mutagenesis. One method 
of saturation mutagenesis is to use a programmable microarray with subsequent PCR 
amplification such as in the technique mutagenesis by integrated tiles (MITE).67 MITE consists 
of the creation of a library of short sequence tiles flanked by adaptor sequences, which are 
synthesised with one single base difference from the consensus sequence. These tiles are 
subsequently inserted into a plasmid containing the rest of the investigated gene. The 
plasmids are then transfected into a cell line, in a concentration ensuring that the majority 
of cells will only contain a single plasmid. The next step of the deep mutational scanning 
process is the classification of cell populations depending on the gene activity. Genes coding 
for enzymes with clear delineated substrates are the easiest to investigate in this manner; 
however, many genes will need to be investigated using indirect reporter genes.67 Using 
fluorescence-activated cell sorting (FACS) with fluorescent antibodies targeting the proteins 
of these reporter genes, populations with lower target gene activity can be isolated, and 
subsequently sequenced to identify the underlying mutation.66, 68 Because of the high volume 
of sequencing, only a massively parallel high-throughput sequencing platform is sufficient. 
Sequencing accuracy can be mitigated with a high number of reads such that individual read 
errors are eliminated as a consequence of the high volume of the consensus sequence. 69 
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Methods of reporter gene discovery 
In order to determine possible reporter genes, genes reported previously in the literature 
can be evaluated using real-time quantitative polymerase chain reaction (qPCR), or 
transcriptomes of cells can be investigated using RNA sequencing (RNAseq) to identify new 
reporter genes. qPCR is a technique that uses complementary DNA (cDNA) synthesised from 
messenger RNA (mRNA) in a PCR reaction that can be tracked using fluorescent probes that 
are specific to individual genes.70 As the PCR reaction proceeds, the number of cycles a gene 
probe needs to reach a particular threshold level of fluorescence can quantify the original 
sample concentration. qPCR is a highly sensitive technique; unfortunately, because it 
requires specific probes, this technique cannot be used to find reporter genes without prior 
Figure 6 Overview of a general approach to deep mutational scanning. First a library is created of all 
possible mutations in the gene of interest. These mutated genes are inserted into plasmids and 
transfected into cells that are subsequently grown in culture. The mutated genes will express the 
protein of interest and the protein will induce expression of a reporter protein, depending on the 
severity of the mutation in the gene. A fluorescent antibody detects the presence of the reporter 
protein and FACS sorts the populations. The cells are then sequenced and the mutations are ranked 
in their severity on the basis of the number of cells expressing the reporter protein. Graphic created 
with Scribus, Inkscape and GIMP. 
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knowledge and is limited to a small number of gene probes for each experiment. In 
attempting to discover new reporter genes, RNAseq can be used to investigate differences 
in gene expression between cell populations.71 Compared to older methods like microarray, 
RNAseq has the advantage of discovering genes in an unbiased manner without 
preconceptions, although it is not as sensitive to weakly expressed genes as qPCR because of 
limited read depth.71, 72 RNA samples used in RNAseq is first isolated from a cell population, 
and then either depleted according to some criteria (rRNA depletion or mRNA selection) or 
used with all RNA available. The resulting RNA is then converted into cDNA and fragmented 
into small sequences with flanking adaptor sequences.72 These fragments are then 
sequenced according to the sequencing technology of choice. A good reporter gene in a 
multiplexed reporter assay is a gene with a substantial difference between populations as 
quantified by fold change (FC), but also high expression in absolute terms. Also, a gene that 
codes for a secreted protein does not work well when using FACS, where a membrane-bound 
protein with extracellular epitopes would be preferable. Selected candidate reporter genes 
can be evaluated using qPCR with populations transfected with either the wildtype or 
mutants with known disease-causing effect. If the possible reporter genes are 
downregulated in the populations transfected with the mutated gene, it may be used as a 
reporter gene if its protein is also detectable. Evaluation of the reporter proteins can be 
performed using Western blot and flow cytometry. While Western blot is able to accurately 
detect the presence of the reporter from a protein lysate, regardless of its intracellular 
localisation, it can only indirectly be used to quantify the expression of the reporter protein. 
Flow cytometry, on the other hand, can accurately quantify the number of cells that express 
the reporter but require different protocols depending on the cellular localisation.73 The 
ability of flow cytometry to also combine different antibodies enables it to find 
subpopulations, such as cells that have been successfully transfected and that express one 
or more reporter proteins. In addition, flow cytometry uses the same underlying technology 
as FACS, a lamellar flow where cells are transported one by one past a detector sensing 
fluorescence, size or complexity.73 The main difference between FACS and flow cytometry is 
the ability of FACS to separate the cells into different containers depending on their 
fluorescence after detection.68 
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Study approach 
As a means to create a deep mutational 
scanning assay for all possible mutations 
in AIRE, we have searched for possible 
reporter genes that can be used to detect 
the functional effect of AIRE mutations. 
The deep mutational scanning pipeline is 
outlined in Figure 7, with the steps within 
the scope of this project outlined in red. 
HEK293FT embryonic kidney cells were 
transfected with a FLAG and MYC tagged 
AIRE, RNA was isolated, and the 
transcriptome investigated using qPCR 
and RNAseq. Genes previously mentioned 
as AIRE dependent in the literature and 
new reporter gene candidates identified 
using RNAseq were investigated using 
qPCR. As a selection strategy, the clinically 
relevant AIRE mutants R257X and C311Y 
were generated and used to check for downregulation of possible reporter genes. In 
addition, we evaluated the viability of RNAseq in identifying weakly expressed genes, 
compared RNAseq and qPCR sensitivity and compared various RNAseq library preparation 
methods. 
Figure 7 Pipeline for the functional screening 
assay using deep mutational scanning. Scope of 




Mutations in AIRE, a unique transcriptional regulator, lead to the rare autoimmune disorder 
APS-1. In order to better our understanding of AIRE, and inform larger sequencing and GWAS 
efforts, our group is developing a multiplexed screening assay to characterise the functional 
effect of any mutation in AIRE. This screening assay uses a deep mutational scanning 
approach, which has previously been used in our group to investigate monogenic diabetes.  
In the process of developing this functional screening assay, a method to check for any 
functional impact of mutations in AIRE needs to be developed. Because of the nature of AIRE, 
it cannot directly be investigated using its binding to a discrete promoter sequence or one 
clear downstream effector. Instead, AIRE induces thousands of genes, some of which may be 
usable as indicators of AIRE function. 
The overall aim of this project has been to develop methods to identify possible reporter 
genes amongst the AIRE induced genes that would be usable in a multiplexed functional 
screening assay. To that effect our main aim can be divided into multiple objectives: 
• Developing a robust cell system with AIRE expression. This cell system needs to be 
amenable to large-scale transfection and FACS sorting, and be robustly expressing 
functional AIRE proteins.  
• Evaluate the cell system for AIRE functionality, investigate the activity of known AIRE 
reporter genes, and evaluate the usability of these genes as possible reporters.  
• Developing a protocol for AIRE inducible gene discovery using RNA sequencing, and 
evaluate different methodological RNAseq approaches.  
• Comparing the performance of different RNAseq approaches to each other and 
compare them to the established method of qPCR. 
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3. Materials and Methods 
Reagents 
All reagents were purchased from Thermo Fisher if not otherwise stated. 
Plasmid amplification and mutagenesis 
In order to express AIRE and AIRE mutants in cell lines, a variety of plasmids were used in this 
work. A pCMV plasmid containing Flag and Myc tagged AIRE wildtype was purchased from 
OriGene (OriGene Cat#: RC213497). This plasmid was used for all AIRE Wt transfections and 
used as a base for creating the AIRE mutations R257X and C311Y as described below. To have 
a positive control of the transfection a plasmid containing Flag and Myc tagged 21-
Hydroxylase (Origene Cat#: RC216416) was used. Plasmids were amplified using TOP10 
competent Escherichia coli cells from Thermo Fisher and purified using a QIAprep Spin 
Miniprep Kit from Qiagen. Mutations were then created using the QuikChange II Site-
Directed Mutagenesis kit from Agilent Technologies (Cat#: 200524-5). The R257X mutation 
was created using mutagenesis primers from Eurogentec with the forward sequence GAA-
GCC-TCT-GGT-TTG-AGC-CAA-GGG-AG and the reverse sequence CTC-CCT-TGG-CTC-AAA-
CCA-GAG-GCT-TC. Similarly, the C311Y mutation was created using mutagenesis primers 
from Eurogentec with the forward sequence GAG-CTC-ATC-TGC-TAT-GAC-GGC-TGC-CC and 
the reverse sequence GGG-CAG-CCG-TCA-TAG-CAG-ATG-AGC-TC. The AIRE and mutated 
AIRE containing plasmids were confirmed to be accurate using Sanger sequencing with the 
Applied Biosystems 3730 DNA analyser. 
Cell culture and transfection 
HEK293FT human embryonic kidney cells (RRID: CVCL_6911) were grown in a medium 
consisting of Dulbecco’s Modified Eagle Medium (Cat#: 31966-021) supplemented with 4.5 
g/l D-Glucose, Pyruvate, 10% (v/v) Fetal Bovine Serum (FBS), and 1% (v/v) Penicillin-
Streptomycin. The cells were incubated at 37°C in a 5% CO2 humidified incubator until 
reaching 80-100% confluency. The cells were subsequently counted using a Countess cell 
counter from Thermo Fisher and transferred to 6-well plates, where each well was seeded 
with 6×105 cells. After 24h, the cells were transfected using the Lipofectamine 2000 
Transfection Reagent from Thermo Fisher with 2.5μg DNA and 12μl Lipofectamine. The cells 
were either transfected with no DNA present (denoted as empty) or with the plasmids 
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previously described. Transfected cells were allowed to grow for 48 hours before being 
harvested. 
Western immunoblotting 
The transfected cells grown for 48 hours were removed from the growing surface by flushing, 
centrifuged at 300g for 7 minutes, then resuspended in Dulbecco’s Phosphate Buffered 
Saline (PBS) purchased from Merck (Cat#: D8537). The cells were then centrifuged a second 
time before the cell pellet was resuspended in cOmplete lysis buffer from Merck (Cat#: 
04719956001) and lysed for 30 minutes on ice. After lysing, the cellular debris was spun down 
using a microcentrifuge at 21130g for 10 minutes, before lysates were pipetted off. 13μl of 
each sample lysate was mixed with 5μl 4X NuPage LDS sample buffer from Merck (Cat#: 
NP0007), and 2μl 10X NuPage Sample Reducing Agent (Cat#: NP0009). The protein lysates 
were then heated at 70°C for 10 minutes, before being applied on a NuPage 10% Bis-Tris gel 
(Cat#: NP0301BOX). In addition to the various samples, the SeeBlue Plus2 Pre-Stained Protein 
Standard (Cat#: LC5925) was applied on the gel. The Lithium dodecyl sulphate 
polyacrylamide gel electrophoresis (LDS-PAGE) was performed using 20X NuPage MOPS 
running buffer (Cat#: NP0001) diluted in Milli-Q water to 1x for the main chamber, and 1x 
MOPS with added 2.5% (v/v) 1X NuPage antioxidant (Cat#: NP0005) for the inner chamber. 
The electrophoresis was accomplished using 180V for 1 hour and 10 minutes. Afterwards, 
the proteins in the gel were transferred to a polyvinylidene difluoride (PVDF) membrane 
using the iBlot dry blotting system from Thermo Fisher (Cat#: IB401002) by using program 3 
for 7 minutes. The membrane was cut into pieces according to the antibodies used, then 
washed three times in Tris Buffered Saline (TBS) with 0.1% (v/v) Tween20 (TBS-T) for 5 
minutes each. After the wash, the membranes were blocked for 1 hour on a shaker in 5% 
(w/v) Blotting-Grade Blocker milk powder from Bio-Rad (Cat#: 1706404) in TBS-T. After 
blocking, the membranes were again washed using the previous method, before being 
incubated with primary antibody in TBS-T with 5% (w/v) Bovine Serum Albumin (BSA) 
overnight on a shaker in a cold room. The primary antibodies used were mouse α-GAPDH 
(Cat#: MAB374, Merck) in a 1:500 dilution, goat α-GAPDH (Cat#: SC-48167, Santa Cruz) in a 
1:500 dilution, mouse α-DDK/FLAG (Cat#: TA50011/OTI4C5, OriGene) in a 1:2000 dilution, 
mouse α-Myc (Cat#: R950-25, Thermo Fisher) in a 1:1000 dilution, goat α-AIRE (Cat#: 
PAB7040, Abnova) in a 1:1000 dilution, mouse α-KRT14 (Cat#: sc-53253 AF647, Santa Cruz) 
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in a 1:500 dilution, and mouse α-S100A8 (Cat#: AM31838FC-N, OriGene) in a 1:500 dilution. 
After probing with primary antibodies, the membranes were rewashed, before being 
incubated with the secondary antibodies in TBS-T with 5% (w/v) BSA for 1 hour on a plate 
shaker. A goat α-Mouse antibody (Cat#: 626520, Thermo Fisher) conjugated with Horse 
Radish Peroxidase (HRP) in a 1:2000 dilution was used for the membranes probed with 
mouse antibodies, while a rabbit α-Goat (Cat#: 611620, Thermo Fisher) antibody conjugated 
with HRP in a 1:2000 dilution was used against the membranes probed with goat antibodies. 
The membranes were rewashed using the previous method, then soaked in Pierce ECL 
Western Blotting Substrate (Cat#: 32106) and imaged using a Bio-Rad Chemidoc. 
Flow cytometry 
Transfected cells grown for 48 hours were harvested by flushing, centrifuged at 300g for 5 
minutes, and resuspended in PBS (Cat#: D8537). The cells were fixed and permeabilised using 
a BioLegend True-Nuclear Transcription Factor Staining buffer set (Cat#: 424401) according 
to the True-Nuclear Transcription Factor Staining Protocol for 5ml tubes. Cells were stained 
using antibodies consisting of rat α-FLAG/DDK conjugated to APC from BioLegend (Cat#: 
637307) in a 1:40 dilution, in a Cell staining buffer, consisting of 5% (v/v) FBS in PBS. The cells 
were subsequently analysed using a BD Biosciences Accuri C6 flow cytometer. The 640nm 
red laser was used to excite the APC conjugated antibodies, while the signal from these was 
detected using a 675nm/25 bandpass filter and the FL4 detector. Results were analysed using 
the FlowJo v10.2 software. 
RNA isolation 
Transfected cells grown for 48h were harvested by flushing, then transferred to 15ml tubes 
where they were centrifuged at 300g for 7 minutes before being resuspended in cold PBS. 
RNA was isolated using Qiagen RNeasy Mini Kit (Cat#: 74106) according to the RNeasy Mini 
Handbook. A Qiagen QIAshredder spin column (Cat#: 79656) was used to homogenise the 
samples, and a Qiagen RNase free DNase solution (Cat#: 79254) was used in order to digest 
any genomic DNA. Afterwards, the RNA samples were stored at -80°C. A NanoDrop 
microvolume spectrophotometer from Thermo Fisher was used to check the RNA 
concentration. In order to be sure that high-quality RNA was used, the samples were also 
analysed using an Agilent Bioanalyzer 2100 with an Agilent RNA 6000 Nano kit (Cat#: 5067-
1511).  
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Real-time quantitative PCR 
Previously isolated RNA was analysed using qPCR in a two-step process. The first step 
consisted of using a Superscript VI VILO cDNA Synthesis Kit with added ezDNase (Cat#: 
11766050) to turn mRNA into cDNA according to the Reverse transcription protocol for 
SuperScript IV VILO Master Mix with ezDNase enzyme. In order to maximise genomic DNA 
digestion of the ezDNase process, 5 minutes incubation time was used. To analyse the cDNA 
a variety of TaqMan probes and a TaqMan Universal PCR Master Mix (Cat#: 4304437) were 
used according to the TaqMan Universal PCR Master Mix User Guide and subsequently 
analysed using an Applied Biosystems 7900HT Fast Real-Time PCR System and the SDS 2.3 
software. Three technical controls for each of three biological replicates were used, in 
addition to no template control (NTC) and no reverse transcriptase control (-RT). TaqMan 
probes were purchased from Thermo Fisher and consisted of probes for the genes GAPDH 
(Cat#: Hs99999905_m1), AIRE (Cat#: Hs00230829_m1), CCNH (Cat#: Hs00236923_m1), IGFL1 
(Cat#: Hs01651089_g1), KRT14 (Cat#: Hs00265033_m1), S100A8 (Cat#: Hs00374264_g1), 
IL10RA (Cat#: Hs00155485_m1), SLC3A2 (Cat#: Hs00374243_m1), ERMAP (Cat#: 
Hs00367924_m1), ARMC5 (Cat#: Hs01000278_m1), SLC7A11 (Cat#: Hs00921938_m1), 
INHBE (Cat#: Hs00368884_g1), and CHAC1 (Cat#: Hs00225520_m1). The qPCR results were 
processed using the ΔΔCT method in Microsoft Excel 2016, and normalised against the 
GAPDH housekeeping gene, then fold change was calculated between the transfected cell 
populations and empty vector.  
RNAseq 
RNA previously isolated was delivered to the Genomics Core Facility at the Department of 
Clinical Science of the University of Bergen, and RNAseq was performed by them. Two 
different library prep kits were used, the Illumina TruSeq Stranded Total RNA Library Prep 
GOLD kit (Cat#: 20020599) and the Illumina TruSeq Stranded mRNA Library Prep kit (Cat#: 
20020595), together with the Illumina TruSeq RNA CD Index Plate index adapters (Cat#: 
20019792). Sequencing was performed with three biological replicates using an Illumina 
HiSeq 4000 sequencer, with a read depth of approximately 100 million reads per sample. 
After sequencing, the resulting fastq files were analysed using the FastQC software to check 
the quality of the data.74 In order to clean the dataset and remove the highly transcribed (up 
to 20%) AIRE reads, the aligner bowtie2 was used with the AIRE cDNA sequence from the 
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plasmid, and the resulting non-aligned reads were retained in new fastq files.75 In bowtie2 
the options --local --phred33 and --un-conc-gz was used. To align the reads from the fastq 
files to the GRCh38.p10 human reference transcriptome the pseudoaligner Kallisto was used 
with the default options.76 After alignment, the transcript alignment was imported and 
summarised into gene alignment using the tximport R-package, and then subsequently 
annotated with gene names using the R-package EnsDb.Hsapiens.v86.77, 78 The resulting 
dataset was analysed for differential expression using the DESeq2 R-package with default 
options.79 In order to visualise the dataset in volcano plots and histograms, the R-package 
ggplot2 was used.80 To investigate the gene ontology of the differentially expressed genes, 
the Gene Ontology enRIchment anaLysis and visuaLizAtion tool (GOrilla) was used to 





Confirming the expression of AIRE and AIRE mutants 
In order to identify AIRE activity reporter genes usable in a deep mutational scanning assay 
and to study the transcriptome of AIRE expressing cells, human HEK293FT embryonic kidney 
cells were transfected with plasmids containing AIRE and AIRE mutants. The cells were either 
left untransfected (Empty), transfected with pCMV6 plasmids containing the FLAG and MYC 
tagged AIRE wildtype (Wt) or transfected with the same plasmids with the recessive 
nonsense mutation R257X or the dominant missense mutation C311Y. Two methods were 
performed to confirm the successful transfection and AIRE expression, western blot and flow 
cytometry. Western blot confirms the expression of the Wt with a distinct band in the 64 kDa 
region using both anti-FLAG and anti-AIRE antibodies (Fig. 8).  
Although slightly larger than the consensus ~57 kDa, the AIRE construct also contains the C-
terminal recognition tags FLAG and Myc, increasing its size. In addition to this band, some 
bands appear in the AIRE Wt fraction using the C-terminal FLAG antibody, and two bands 
appear when using the N-terminal AIRE antibody, suggesting some degradation of AIRE. The 
population transfected with the AIRE R257X mutant shows no bands using the FLAG 
Figure 8 Confirmation of wildtype and mutant AIRE expression using Western blot. Lysates isolated 
from untransfected HEK293FT cells (Empty) or cells transfected with AIRE wildtype or the mutants 
R257X and C311Y. Both anti-FLAG and anti-AIRE antibodies were used in order to confirm AIRE bands, 
and to detect the truncated R257X mutant which lacks the FLAG tag. Skewed blot is responsible for 
any marking at the top of the Empty cell lysate. Detection of GAPDH in the anti-flag part of the blot 
only, was used as a loading control. The image is representative of two independent experiments.  
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antibody, yet gets a band at approximately 30 kDa unique to this population with the AIRE 
antibody. This size is consistent with the R257X mutation as this mutation is a nonsense 
mutation that leads to a truncated AIRE protein, with a theoretical molecular weight of 27.7 
kDa (estimated using ProtParam83). The premature stop codon is also responsible for the lack 
of a FLAG sequence in this AIRE mutant. The cell population transfected with the C311Y 
mutant shows a weak band at the 65 kDa position, with the majority of AIRE in various bands 
between ~35-50 kDa, concordant with considerable degradation of this mutant.  
Flow cytometric analysis of cells transfected with AIRE Wt or the positive control 21-
hydroxylase (21OH) in a similar vector shows an increase of 40.8% and 55.5% FLAG-positive 
cells respectively, compared to untransfected cells (Fig. 9) when using anti-FLAG primary 
antibodies conjugated to the fluorochrome APC. Initial gating for cells can be seen in a, while 
b shows the gating for FLAG-positive cells, and c shows a histogram overview of the same 
FLAG gate. Transfection efficiency of AIRE Wt has subsequently increased to ~65% while 
analysis of the C311Y mutant shows a comparable increase in 66% of FLAG-positive cells 
compared to the untransfected population (Fig. 10).  
Confirming AIRE activity using qPCR of known AIRE-responsive genes  
Having confirmed AIRE expression with both western blot and flow cytometry, AIRE activity 
was investigated using qPCR. To find AIRE reporter gene candidates using RNAseq, AIRE does 
not only need to be present but actively inducing target gene expression in cell populations. 
From the literature, we selected AIRE-induced genes Insulin Growth Factor-Like Family 
Member 1 (IGFL1), Keratin 14 (KRT14) and S100 Calcium Binding Protein A8 (S100A8) as 
activity probes, while Cyclin H (CCNH) was selected as a negative control not affected by AIRE. 
The housekeeping gene Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) was used to 
normalise expression among populations. Substantial AIRE overexpression was found, with 
a fold change increase of around 250 thousand times in the AIRE Wt and the C311Y mutant 
transfected cell populations compared to untransfected cells, and around 550 thousand 
times increased expression in the R257X mutant (Fig. 11).  The AIRE un-regulated control 
gene CCNH shows a fold change hovering around 1 for all populations, though slightly higher 
in the two mutant populations. 
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Figure 9 Confirmation of AIRE expression using flow cytometry analysis. Untransfected cells, or cells transfected with AIRE 
Wt or the positive control 21-hydroxylase (21OH) were permeabilised and stained with anti-FLAG antibodies. Initial gating 
strategy shown in a, while b shows gating for the presence of the FLAG tag (APC/FL4), either on AIRE or 21OH. Histogram of 
gating for FLAG positive cells shown in c. Transfection efficiency estimated as ~41% for AIRE and ~56% for 21OH.  
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Figure 10 Confirming expression of the AIRE mutant C311Y using flow cytometry.  Untransfected HEK293FT cells or cells 
transfected with AIRE Wt or the C311Y mutant permeabilised and stained using anti-FLAG antibodies. Initial gating strategy 
shown in a, while gating for the presence of FLAG (APC/FL4) shown in b, histogram of gating for the FLAG positive 
population shown in c. Transfection efficiency estimated as ~65% for the wildtype and ~66% for the C311Y mutant. Flow 
cytometry analysis of the R257X mutant using anti-FLAG antibodies was not possible because of its truncated nature.  
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Of the AIRE influenced genes; IGFL1 shows a fold change increase of 11.6 times in the AIRE 
Wt compared to the untransfected cell population, and although this decreases to 0.9 in the 
C311Y mutant, the R257X mutant shows similar expression to Wt with a fold change of 11.9. 
The KRT14 gene shows an increase of 7.7 in the Wt compared to the untransfected cells, a 
reduction to 0.9 in the C311Y mutant, and slightly less reduction in the R257X mutant at 3.3. 
The S100A8 gene increases to 6.0 in the Wt compared to the untransfected cells, with a 
decrease to 1.3 in the C311Y mutant and 2.5 in the R257X mutant. The increase in gene 
expression of all three AIRE reactive genes in the Wt suggests that AIRE is functional. In 
addition, the reduced expression of KRT14 and S100A8 in the AIRE mutants make them 

































































































Figure 11 Confirming AIRE activity. RNA from untransfected cells and cells transfected with AIRE wildtype or the AIRE 
mutants C311Y and R257X were used in qPCR analyses. TaqMan probes were used for AIRE, the negative control CCNH, 
and the purported AIRE regulated genes IGFL1, KRT14 and S100A8. Results were normalised against the housekeeping 
gene GAPDH. The ΔΔCT method was used to compare the AIRE Wt and mutants with the untransfected control and the 




Figure 12 RNAseq analysis comparing the transcriptome of AIRE transfected HEK293FT cells with untransfected cells. Genes 
with lower than 0.05 FDR adjusted p-values (padj) were selected for visualisation. Volcano plot in a of the differential 
expression between the populations in log2 Fold Change on the X-axis and significance in -log10 FDR adjusted p-values on the 
y-axis.  Genes with a log2 fold change above 1 or below -1 are marked in red. Names are given for the top and bottom 10 
genes in log2 foldchange. Histogram of the differential expression in b. RNAseq was performed with three biological 




Figure 13 Gene ontology overview 
of differentially expressed genes 
between AIRE Wt and 
untransfected cells. Significant 
genes (<0.05 padj) were separated 
into ranked lists where one was 
upregulated and one 
downregulated. These lists were 
used as input for GOrilla with a 
significance cut-off at 10-3 and the 
resulting gene ontology process list 
was used as input for Revigo, and 
visualised with the Treemap R-
package. The area of each category 
corresponds with its significance in -
log10 p-value. The lists contained 
4852 and 3632 upregulated (a) and 






Gene FPKM Fold Change FDR 
Membrane 
bound APS-1 related Abramson 2010 (microarray) 




IL10RA 8.86 2.80 0.0140 Yes No Yes (0.9) 
ERMAP 9.65 1.62 0.0347 Yes No No 
SLC3A2 14.09 1.50 0.0151 Yes No No 
SLC7A11 12.14 4.78 0.0021 Yes No Yes (5.4) 
CHAC1 11.01 9.97 0.0049 No No Yes (2.8) 
Identifying new AIRE activity reporter genes using RNA sequencing  
Having confirmed that AIRE is present and active in the transfected cell populations, 
transcriptome analysis using RNAseq was performed to identify additional possible reporter 
genes for the deep mutational scanning assay. RNA was isolated from AIRE transfected and 
untransfected cells, confirmed as high quality (RIN >9) using a bioanalyzer 2000 and prepped 
for sequencing using a TotalRNA with ribosomal RNA depletion library preparation kit. 
Sequencing was performed using an Illumina NextSeq 4000 sequencer, and data were quality 
checked using FastQC. Alignment to the human reference genome (GRCh38) was performed 
using the pseudoaligner Kallisto, and differential expression analysis was accomplished using 
DEseq2. The resulting volcano plot of 8484 genes with less than 0.05 FDR adjusted p-values 
comparing the AIRE Wt against the untransfected transcriptome (Empty) can be seen in 
figure 12. Both upregulated and downregulated genes are apparent, with 4852 upregulated 
genes and 3632 downregulated genes, although the majority of highly differentially 
expressed genes were upregulated. Gene ontology enrichment of the significantly 
differentially expressed genes shows upregulation of genes related to the unfolded protein 
response (UPR), and a downregulation of a variety of pathways (Fig. 13).  In order to select 
some candidate reporter genes from amongst the subset of significantly upregulated genes, 
a selection strategy was needed. The principal criteria chosen were genes with high and 
significant differential expression, high absolute expression, and encoding a membrane-
bound protein to facilitate easier FACS sorting. Additionally, some factors strengthened a 
candidate genes case, such as being known as related to APS-1 manifestations or appearing 
in previous microarray studies of AIRE transcriptomes43. The resulting genes can be seen in 
Table 1.  
Table 1 AIRE reporter gene candidate selection strategy. Genes from the RNAseq were selected according to high 
expression in FPKM and higher expression in AIRE transfected cells compared to untransfected in fold change. Genes were 
subsequently selected for their significance in FDR. Additional criteria were a preference for membrane bound proteins 
for easier flow cytometry detection, a link with APS-1 symptoms, and detection in previous studies using microarray.43 
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qPCR analysis for validation and evaluation of candidate reporter genes from 
transcriptome comparisons  
The previously identified candidate reporter genes with high expression in AIRE transfected 
cell populations and low expression in untransfected cells were investigated using qPCR with 
RNA from untransfected cells and cells transfected with AIRE Wt and the mutants R257X and 
C311Y (Fig. 14). Interleukin 10 Receptor Subunit Alpha (IL10RA) exhibits slightly increased 
expression in the AIRE Wt and C311Y mutant populations, while R257X shows a substantial 
increase in fold change difference from untransfected cells. Similarly, Solute Carrier Family 3 
Member 2 (SLC3A2) shows a gradual increase in expression from the AIRE Wt to the C311Y 
and finally the R257X mutant with the most substantial difference in expression. The same 
pattern can be seen in Erythroblast Membrane Associated Protein (ERMAP) and Armadillo 
Repeat-Containing Protein 5 (ARMC5) with R257X having the highest expression but with 
AIRE Wt having little if any difference from untransfected cells. Solute Carrier Family 7 
Member 11 (SLC7A11) does have increased expression in AIRE Wt compared to empty, and 
reduced expression in C311Y compared to Wt, yet R257X is still the highest expressing 
population. Inhibin Beta E Subunit (INHBE) and ChaC Glutathione Specific Gamma-
Glutamylcyclotransferase 1 (CHAC1) show little or no difference between the three cell 
populations even if they all have substantially increased expression compared to the 
untransfected cells. Comparing the results of the RNAseq with the qPCR, the values correlate 
quite well, although the RNAseq values are generally lower (Fig. 15). As none of these 
candidate reporter genes exhibits the preferred properties, namely increased expression in 
cells transfected with AIRE Wt and reduced expression compared to Wt in cells transfected 










































































































Figure 14 Evaluating reporter genes using qPCR analyses. RNA isolated from untransfected cells, cells transfected with 
AIRE wildtype, or the AIRE mutants C311Y and R257X was used to evaluate the suitability of the previously selected 
reporter gene candidates. TaqMan probes were utilised for the previously identified candidate reporter genes IL10RA, 
SLC3A2, ERMAP, ARMC5, SLC7A11, INHBE, and CHAC1. All gene expression was normalised using the housekeeping gene 
GAPDH. The ΔΔCT method was utilised to calculate the difference of expression in Fold Change between the transfected 
cells and the untransfected control. Three technical and three biological replicates for each cell population were used. 
Figure 15 Comparison of RNAseq 
and qPCR fold change. 
Comparison of fold change 
between RNAseq and qPCR. Data 
from the genes CHAC1, ERMAP, 
INHBE, SLC3A2, SLC7A11, 
ARMC5, IL10RA. RNAseq data 
taken from AIRE Wt vs empty 
TotalRNA (Fig. 12) and qPCR data 
taken from figure 14. 
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Figure 16 Differential gene expression analysis from RNAseq of R257X and AIRE Wt transfected cells. Genes with a 
significance threshold of less than 0.05 FDR adjusted p-values (padj) visualised in a volcano plot (a) and histogram (b). The 
volcano plot ranks the differential expression in log2 Fold Change on the x-axis and the significance in -log10(padj) on the 
y- axis. Genes with higher than 1 and lower than -1 log2 Fold Change are marked in red. The top 10 and bottom 10 log2 Fold 
Change genes are marked with names. RNAseq was performed with three biological replicates, and library preparation 
performed using a TotalRNA with ribosomal RNA reduction kit. 
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Figure 17 Gene ontology overview of 
differentially expressed genes 
between R257X and AIRE Wt 
transfected cells. Significant genes 
(<0.05 padj) were separated into 
ranked lists where one was 
upregulated and one downregulated. 
These lists were used as input for 
GOrilla with a significance cut-off at 
10-3 and the resulting gene ontology 
list was used as input for Revigo, and 
visualised with the Treemap R-
package. The area of each category 
corresponds with its significance in -
log10 p-value. The lists contained 
3947 and 4442 upregulated (a) and 





Finding reporter genes using RNAseq of AIRE mutants 
To narrow down the population of genes suitable for use as AIRE activity reporter genes, we 
performed a new series of RNAseq experiments. To find a subset of genes that were 
upregulated in AIRE Wt transfected cells compared to untransfected cells, but 
downregulated in AIRE mutants compared to the Wt, the AIRE mutants R257X and C311Y 
were analysed and compared with Wt. The subset of genes with a significance of less than 
0.05 FDR adjusted p-value (padj) was visualised using volcano plots. The 8389 significant 
differentially expressed genes when comparing the R257X mutant and AIRE Wt can be seen 
in figure 16 where 3947 genes show upregulation and 4422 genes show downregulation. 
Despite the majority of genes showing downregulation, the majority of highly differentially 
expressed genes with a log2 fold change of higher than 1 or lower than -1 is situated within 
the upregulated population. Figure 17 visualises the enriched gene ontology terms of the 
biological processes involving these genes. A variety of processes are upregulated, but with 
the most significant processes in the downregulated population being glycerol biosynthesis 
and UPR. Comparing the transcriptome of AIRE mutant C311Y with the Wt found 2540 
differentially expressed genes with a significance of less than 0.05 FDR adjusted p-value 
(padj) with 759 upregulated genes and 1782 downregulated genes. Overall, there was little 
difference between the cell populations, with only one gene with a log2 fold change below -
1 (Fig. 18).   
In an attempt to increase the likelihood of finding differentially expressed genes with a low 
absolute expression and comparing the performance between different RNAseq methods, 
we next set up an equivalent experiment using an mRNA library preparation kit with polyA 
tail capture. The RNA isolated from transfected and untransfected cells were then analysed 
using this preparation method. The comparison of differentially expressed genes with a 
significance of less than 0.05 FDR adjusted p-values (padj) between R257X and Wt can be 
seen in figure 19, with 10073 significant genes of which 4657 were upregulated, and 5417 
were downregulated. Similar to the first RNAseq of these populations (Fig. 16), the majority 
of highly differentially expressed genes with a log2 fold change of higher than 1 and lower 




Figure 18 Differential gene expression analysis from RNAseq of C311Y and AIRE Wt transfected cells. Genes with a 
significance threshold of less than 0.05 FDR adjusted p-values (padj) visualised in a volcano plot (a) and histogram (b). The 
volcano plot ranks the differential expression in log2 Fold Change on the x-axis and the significance in -log10(padj) on the y-
axis. Genes with higher than 1 and lower than -1 log2 Fold Change are marked in red. The top 10 and bottom 10 log2 Fold 
Change genes are marked with names. RNAseq was performed with three biological replicates, and library preparation 
performed using a TotalRNA with ribosomal RNA reduction kit. 
 
 43 
Figure 20 shows the significantly differentially expressed genes between C311Y and Wt; a 
total of 2299 significant genes were found, of which 1012 genes were found to be 
upregulated, and 1287 were downregulated. However, no genes had a higher log2 fold 
change than 1 or lower than -1 in this comparison. The RNAseq approach used in this 
experiment is unable to detect an identifiable highly differentially expressed downregulated 
population in the AIRE mutants. Thus, the focus changed to evaluate and compare the 
RNAseq setup. 
Comparing RNAseq library preparation methods 
In order to compare the two library prep methods, transcriptomes of AIRE Wt were 
compared with untransfected (empty) cells and significantly differentially expressed genes 
were visualised in figure 21. A total of 4443 genes were found to be differentially expressed, 
where 2108 genes were found to be upregulated, and 2335 were downregulated. Similar to 
the comparison using TotalRNA library preparation (Fig. 12), the mRNA method shows more 
highly differentially expressed genes in the upregulated portion, though the number of genes 
with a log2 fold change above 1 or below -1 is less than the first RNAseq. A comparison of 
the log2 fold change distribution of the mRNA compared to the TotalRNA RNAseq, plotted in 
figure 22a shows that the mRNA population trends closer to 0 compared to the TotalRNA 
population, with generally lower differential expression in log2 fold change. Comparing the 
absolute expression in transcripts per million (TPM) both the Wt (Fig. 22b) and untransfected 
(Fig. 22c) populations show mostly similar expression, although a variety of genes show 
higher expression using the mRNA library kit. 
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Figure 19 Differential gene expression analysis from RNAseq of R257X and AIRE Wt transfected cells. Genes with a 
significance threshold of less than 0.05 FDR adjusted p-values (padj) visualised in a volcano plot (a) and histogram (b). The 
volcano plot ranks the differential expression in log2 Fold Change on the x-axis and the significance in -log10(padj) on the y-
axis. Genes with higher than 1 and lower than -1 log2 Fold Change are marked in red. The top 10 and bottom 10 log2 Fold 
Change genes are marked with names. RNAseq was performed with three biological replicates, and library preparation 
performed using a mRNA with polyA tail capture kit. 
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Figure 20 Differential gene expression analysis from RNAseq of C311Y and AIRE Wt transfected cells. Genes with a 
significance threshold of less than 0.05 FDR adjusted p-values (padj) visualised in a volcano plot (a) and histogram (b). The 
volcano plot ranks the differential expression in log2 Fold Change on the x-axis and the significance in -log10(padj) on the y- 
axis. The top 10 and bottom 10 log2 Fold Change genes are marked with names. RNAseq was performed with three biological 




Figure 21 Differential gene expression analysis from RNAseq of AIRE Wt and untransfected (empty) cells. Genes with a 
significance threshold of less than 0.05 FDR adjusted p-values (padj) visualised in a volcano plot (a) and histogram (b). The 
volcano plot ranks the differential expression in log2 Fold Change on the x-axis and the significance in -log10(padj) on the y- 
axis. Genes with higher than 1 and lower than -1 log2 Fold Change marked in red. Top 10 and bottom 10 log2 Fold Change 
genes marked with names. RNAseq performed with three biological controls, and library preparation performed using a 
mRNA with polyA tail capture kit. 
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Confirming and evaluating RNAseq 
In order to confirm the previous RNAseq experiments 
and to evaluate how representative they were, a new 
independent set of experiments were performed. 
Plasmids were sequenced to confirm their gene 
inserts, plasmids were reamplified, new cells were 
transfected, and RNA was subsequently isolated. 
RNAseq was performed again using the mRNA library 
preparation kit with RNA isolated from AIRE Wt, R257X 
and C311Y transfected cells.  
Differential gene expression between the R257X 
mutant and AIRE Wt transfected cells, found 8329 
genes with a significance of less than 0.05 FDR 
adjusted p-values. Of these significantly differentially 
expressed genes, 3658 genes were found to be 
upregulated, and 4673 genes were downregulated. 
These genes are visualised in figure 23.  The majority 
of highly differentially expressed genes with a log2 fold 
change above 1 or below -1 were found to be 
upregulated, similarly to previous differential 
expression analysis of this comparison. Comparing the 
transcriptomes of C311Y and Wt found just 49 
differentially expressed genes, where 5 of these were 
upregulated, and 44 were downregulated (Fig. 24). 
None of these genes was highly differentially 
expressed. 
Figure 22 Comparison of RNAseq runs with different 
preparation method. RNAseqs with mRNA and TotalRNA 
library kit setups compared. The log2 fold change of first 
and second RNAseq of AIRE Wt vs untransfected (empty) is 
compared in a. The transcripts per million (TPM) of each 
gene in the AIRE Wt population is compared in b, and the 
TPM of the genes in the untransfected population is 





Figure 23 Differential gene expression analysis from RNAseq of R257X and AIRE Wt transfected cells. Genes with a 
significance threshold of less than 0.05 FDR adjusted p-values (padj) visualised in a volcano plot (a) and histogram (b). The 
volcano plot ranks the differential expression in log2 Fold Change on the x-axis and the significance in -log10(padj) on the y- 
axis. Genes with higher than 1 and lower than -1 log2 Fold Change are marked in red. The top 10 and bottom 10 log2 Fold 
Change genes are marked with names. RNAseq was performed with three biological replicates, and library preparation 
performed using a mRNA with polyA tail capture kit. 
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Figure 24 Differential gene expression analysis from RNAseq of C311Y and AIRE Wt transfected cells. Genes with a 
significance threshold of less than 0.05 FDR adjusted p-values (padj) visualised in a volcano plot (a) and histogram (b). The 
volcano plot ranks the differential expression in log2 Fold Change on the x-axis and the significance in -log10(padj) on the y- 
axis. The top 10 and bottom 10 log2 Fold Change genes are marked with names. RNAseq was performed with three biological 
replicates, and library preparation performed using a mRNA with polyA tail capture kit. 
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Figure 25 Comparison of RNAseq runs. RNAseqs 
with the same technical mRNA library kit setup 
but different biological experiments are 
compared. The log2 fold change of the second 
and third RNAseq of R257X vs AIRE Wt is 
compared in a. The transcripts per million (TPM) 
of each gene in the R257X mutant population is 
compared in b, and the TPM of the genes in AIRE 
Wt is compared in c. Comparison of log2 fold 
change of the C311Y vs AIRE Wt RNAseqs is 
shown in d, while e shows the comparison of 




Comparing the RNAseq of the same technical setups but with different biological 
experiments, the log2 fold change values of significant genes in the R257X compared to Wt 
trend slightly more towards 0 in the last RNAseq, although this deviation is very modest (Fig. 
25a). The TPMs of the genes in the R257X transfected cell population are remarkably stable 
across experiments as seen in figure 25b. This is also true for the Wt transfected cells, 
although with a slight increase of TPM in genes for the last RNAseq (Fig. 25c). Comparing the 
differentially expressed genes between two analyses of the C311Y and Wt populations, the 
majority of genes are not differentially expressed in the last RNAseq (Fig. 25d). However, 
when looking at the absolute expression in TPM for genes in the C311Y population, the 
RNAseqs correlates very well, with a slightly higher expression in the last RNAseq (Fig. 25e).  
In order to compare how well the RNAseq analyses correlates with the previously performed 
qPCR, absolute expression values from RNAseq were compared to CT values from qPCR of 
the same RNA isolates (Fig. 26). The TPM from RNAseq correlates well with CT values, with 
an R2 of 0.87. Importantly the previously reported gene candidates KRT14 and S100A8 are 
not significantly identified using RNAseq, with a TPM of 0.07 and 0.04 respectively. 
Figure 26 Comparison of 
RNAseq and qPCR. Comparison 
of transcript per million (TPM) 
from RNAseq with CT values 
from qPCR analysis of the same 
biological experiments. Data 
from the genes IGFL1, KRT14, 
S100A8, CHAC1, ERMAP, INHBE, 
SLC3A2, SLC7A11, ARMC5, 
IL10RA, GAPDH, ACTB, CCNH. 
The second run of RNAseqs with 
R257X and C311Y vs Wt using 
TotalRNA library kit used for TPM 
and count values. 
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5. Discussion 
AIRE, the autoimmune regulator, is a potent transcriptional regulator able to induce 
expression of thousands of repressed genes. This makes AIRE crucial for the process of 
negative selection, in which T-cells get controlled for their ability to recognise the body’s own 
proteins. Mutations in AIRE are responsible for the rare autoimmune disorder APS-1. Such 
mutations have been found within all of AIREs functional domains, yet the patient 
phenotypes differ in their severity depending on the underlying mutation. Most AIRE 
mutations are inherited recessively, but some dominant mutations have been identified.  
AIRE expression is tightly controlled and occurs primarily in mTECs in the medulla of the 
thymus. The AIRE protein consists of a number of functional domains; a CARD protein 
dimerisation domain, a SAND general DNA interaction domain, and two PHD zinc fingers for 
protein interaction. AIRE functions by recognising and inducing transcription of repressed 
genes. This recognition is performed by PHD zinc fingers interacting with unmethylated 
histone tails, or by recognition of the repressive ATF7ip-MBD1 complex. AIRE then recruits a 
number of proteins into an efficient transcriptional machinery. Because AIRE does not target 
specific genes or promoters like other transcriptional regulators but instead targets any 
repressed gene in a cell, AIRE induces different genes depending on which cell type it is active 
in. In addition, AIRE activity is stochastic, in that different cells will have different genes 
induced by AIRE. However, all AIRE regulated genes will be induced on a population level. 
APS-1 is characterised by the three main manifestations of Addison’s disease, 
hypoparathyroidism, and chronic mucocutaneous candidosis. However, APS-1 patients may 
not have all of these symptoms and may exhibit a variety of other symptoms unique to that 
patient. This means that some APS-1 patients may be undiagnosed, or diagnosed with other 
autoimmune diseases. With the increasing number of large-scale sequencing and GWAS 
studies of patients, novel AIRE mutations, especially mutations with a moderate phenotypic 
effect, may be found and linked to other diseases. 
While AIRE has been a focus of much research since its identification in 1997, many questions 
still remain regarding AIRE function and interaction. The characterisation of AIRE mutations 
may improve our understanding of AIRE function, allow for better diagnosis of a number of 
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patients with an atypical APS-1 phenotype, and inform large-scale GWAS and sequencing 
efforts. 
The current thesis is part of a larger project where the long-term aim is to develop a 
multiplexed screening assay for AIRE function, by the use of a deep mutational scanning 
approach. This would allow characterisation of the functional effect of all theoretically 
possible mutations in AIRE. As a means to identify possible reporter genes for AIRE activity 
that could be used as a part of this multiplexed assay, we transfected HEK293FT human 
embryonic kidney cells with AIRE and AIRE mutants and analysed the transfected populations 
using RNAseq and qPCR.  
Establishing an experimental system for functional investigation of AIRE variants 
In order to investigate AIRE in a high throughput assay, a highly expressing and fast-growing 
cell system is needed. To that effect, HEK293FT cells were transfected with pCMV6 plasmids 
containing FLAG and Myc tagged AIRE, and the AIRE mutants R257X and C311Y.  
The western blot confirmed AIRE and AIRE mutant expression in this cell-system (Fig. 8), with 
AIRE exhibiting a band approximately 64 kDa, slightly higher than the estimated 61 kDa of 
AIRE with FLAG and Myc tags (ProtParam83). The R257X mutant was detected using N-
terminal recognising anti-AIRE antibodies, exhibiting a major band at approximately 30 kDa, 
consistent with estimates (ProtParam83) and previous studies.36 This band was unique for the 
R257X mutant. As expected, the R257X mutant was not detected using anti-FLAG antibodies 
since its premature stop codon prevents the expression of the C-terminal FLAG tag. To our 
knowledge, the C311Y mutant has not been previously investigated using western blotting 
but was identified using both anti-FLAG and anti-AIRE antibodies with a weak band at the 
consensus size of 64 kDa, yet with substantial degradation.  
Detection of FLAG-positive cells using flow cytometry confirmed the presence of AIRE and 
allowed for a quantification of the percentage of cells successfully transfected. Initial 
transfection showed a moderate transfection efficiency of approximately 41%, comparable 
to but less than the positive control 21OH at approximately 56% transfection efficiency (Fig. 
9b and 9c). However, the transfection efficiency has thereafter increased to approximately 
65% for AIRE Wt with a conservative gating strategy, and comparably 66% for the C311Y AIRE 
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mutant (Fig. 10b and 10c). The reason for this increase is uncertain but may reflect increased 
proficiency with transfection and flow-cytometry in general. 
Characterising AIRE protein degradation as a result of overexpression and mutant 
instability 
Our setup of using two different antibodies with binding affinity on each extremity of the 
AIRE protein in the western blot allows for estimation of the location of the exhibited protein 
degradation. AIRE Wt exhibited some degree of degradation with three products located 
approximately between 40 and 50 kDa using the C-terminal antibodies, and a band at 30 kDa 
and about 20 kDa detectable using the N-terminal antibodies (Fig. 8). These band sizes 
suggest an N-terminal degradation located between the PHD1 and CARD domain. The R257X 
mutant is only detectable using the N-terminal antibody, yet in addition to the dominant 
band slightly above 30 kDa, it does exhibit the same 30 and 20 kDa degraded bands as 
detected in the Wt blot. The C311Y blot exhibited considerable degradation, with a weak 
consensus band in both blots, but with many degraded bands in the C-terminal blot with a 
size between 35 and 50 kDa, and a few bands in the sub-25 kDa size. In addition, C311Y 
exhibited the two 30 and 20 kDa bands in the N-terminal blot, consistent with both other 
AIRE variants. Again, this suggests degradation from the N-terminal side between the CARD 
domain and the first PHD finger, in addition to some degradation responsible for a construct 
only containing one or two PHD domains and the FLAG sequence. It is possible that the two 
sub-30 kDa bands detected using N-terminal anti-AIRE antibodies is due to unspecific 
binding, yet these bands do not seem to appear using the negative control of the 
untransfected cells.  
The substantial degradation of the C311Y mutant suggests that this is a very unstable protein. 
Causative for this instability may be the removal of the stabilising zinc-binding motif of the 
primary PHD zinc finger previously reported in this mutant.57 As such, this instability may at 
least partially point to how this mutant is dominant, by producing a full-length AIRE protein 
without the necessary fold for the action of PHD1 and PHD2 in the AIRE multimer. 
Confirming functional AIRE by AIRE gene induction 
After successfully establishing the cell system as AIRE and AIRE mutant expressing, the cell 
system was evaluated for AIRE gene induction, to confirm a functional AIRE protein. 
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qPCR analysis of AIRE and AIRE mutants showed an extremely high fold change of AIRE in 
transfected cells (Fig. 11), and RNAseq data confirms that AIRE is responsible for up to 20% 
of all reads in the experiment (data not shown). In fact, AIRE Wt and the C311Y mutant 
expression were at 251 and 269 thousand times that of untransfected cells respectively, 
while the AIRE mutant R257X had a two-fold higher expression than Wt. Gene ontology 
enrichment of these populations showed that the UPR was upregulated in the AIRE Wt 
transfected populations compared to untransfected cells (Fig. 13a). It could be speculated 
that this may be a response to the extreme transcription of AIRE in these cells saturating the 
endoplasmic reticulum (ER) and is consistent with the substantial degradation found for the 
Wt and C311Y variants using western blot. However, when analysing the gene ontology 
enrichment of the comparison between the R257X mutant and the AIRE Wt, the UPR is 
amongst the downregulated population of genes (Fig. 17b). Thus, it seems that the UPR 
effect is restricted to the Wt and possibly the C311Y mutant which has overall similar 
expression. The reason for this discrepancy is difficult to disentangle based on the current 
experiments. The R257X mutant encodes a truncated protein, with an estimated and 
observed size at approximately 30 kDa (Fig. 8) and thus may be more efficiently translated, 
have fewer problems in folding, and may activate the UPR to a lesser degree than the AIRE 
Wt. However, it may also be the opposite, that the triggering of the UPR to a lesser extent, 
allows for increased transcription of the R257X mutant. Alternatively, it may just reflect the 
fact that a shorter DNA sequence allows for faster transcription, and the higher fold change 
of R257X may not reflect an actual increase in protein synthesis. 
The qPCR analysis of the known AIRE-dependant genes IGFL1, KRT14 and S100A8 showed an 
increased transcription in AIRE Wt populations compared to untransfected cell populations 
(Fig. 11). This result is consistent with the literature, where these genes are described as 
highly AIRE-dependant in Wt transfected HEK293T cells.43 Furthermore, the degradation of 
AIRE Wt, as evident from the western blots, does not seem to influence the functional activity 
of AIRE. When comparing the transcription of these genes in the C311Y mutant, all three 
genes had lower expression. However, while the R257X mutant showed decreased 
transcription in KRT14 and S100A8, the transcription of IGFL1 is not reduced. The results of 
KRT14 and S100A8 are consistent with previous studies involving AIRE and AIRE mutant 
transfected 4D6 cells, while IGFL1 expression was previously reported to be reduced with 
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R257X.57 The reason for this discrepancy is unclear, but explanations may involve cell-specific 
differences: Because of AIRE’s targeting of epigenetically or actively repressed genes any 
difference in which genes are repressed between differentiated cells will lead to a different 
AIRE induced transcriptome.28, 35 Thus, any reporter gene system will by necessity be cell 
specific, and while being able to accurately predict AIRE mutational effect, will not be as 
representative for actual transcriptome changes in patient cells.  
These results show that KRT14 and S100A8 exhibit the desired properties of reduced 
expression for the AIRE mutants compared to Wt and may be taken forward as potential AIRE 
reporter genes in a functional screening assay using HEK293FT cells. 
However, both of these candidates exhibited only the first of our preferred reporter gene 
traits:  
• High and significant differential expression between wildtype and mutants 
• High expression in absolute terms  
• Encoding cell surface proteins for easier FACS sorting.  
Thus, in order to identify unknown AIRE regulated genes suiting these criteria, RNA 
sequencing was utilised. 
Transcriptome sequencing of wildtype AIRE to identify candidate reporter genes 
Having confirmed that AIRE is highly transcribed, translated, and able to induce the 
expression of known AIRE target genes, we next set out to identify novel reporter genes using 
transcriptome sequencing.  
The first RNAseq performed, comparing the AIRE Wt transfected population with 
untransfected HEK293FT cells, showed a large number of significantly upregulated genes 
(Fig. 12), albeit most of them with a relatively modest log2 fold change. A similar experiment 
using stably transfected HEK293 cells with doxycycline-induced AIRE Wt expression reported 
691 upregulated genes, and one downregulated gene with a threshold of 1 and -1 log2 fold 
change respectively.84 This is comparable to our result, which found 219 upregulated genes 
and 32 downregulated genes using the same thresholds. A large number of upregulated 
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genes are consistent with previous studies using mTEC cells from Wt and knockout mice, yet 
our result does have a more substantial number of downregulated genes with lower 
differential expression.47 However, this may be explained by the aforementioned cell-specific 
differences in AIRE transcriptomes.  
Evaluation of candidate reporter genes identified from RNAseq analysis using qPCR 
We selected putative reporter genes from the list of upregulated genes in the previous 
RNAseq, according to the selection strategy outlined in table 1. These genes were 
subsequently investigated using qPCR with gene-specific TaqMan probes. However, the 
result of this investigation did not yield any viable reporter genes fulfilling our preferred 
properties (Fig. 14). While the results of the qPCR did correlate well with the RNAseq result 
in the comparison between AIRE Wt and untransfected cells (Fig. 15), they did not show 
decreased expression in the AIRE mutants compared to the Wt. Hence, these genes may be 
upregulated not because of the transcriptional activity of AIRE, but rather as a response to 
the transfection. In retrospect, it might have served as a better control to use a plasmid 
without an AIRE insert in the comparison with AIRE Wt.  
Another notable finding regarding the qPCR result was the increased expression of some of 
these candidate reporter genes in the R257X mutant compared to the Wt. This might further 
strengthen the suspicion that these genes are upregulated as a result of the transfection, or 
as a more unspecific result of the very high level of AIRE expression found for this variant 
(Fig. 11).   
A reassuring finding of these analyses came from the comparison of all qPCR results with 
their comparative RNAseq results of the same biological RNA sample. We found a very robust 
correlation between the RNAseq and qPCR results with an R2 of 0.87 indicating that the 
results from RNAseq are very robust (Fig. 26). 
Change of RNAseq strategy to isolate transcriptome differences between AIRE wildtype 
and mutants 
As a consequence of our inability to identify reporter genes merely using the AIRE Wt and 
untransfected cell comparison, the experimental strategy was changed to attempt to identify 
reporter genes using a comparison between AIRE mutants and the Wt. This would allow for 
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identification of genes that are the result of AIRE expression, yet are impaired when AIRE 
function is hampered. The Wt and the known mutants R257X and C311Y were investigated 
using an identical RNAseq approach as in the initial experiment. Differential gene expression 
analysis of the R257X mutant showed a majority of upregulated genes compared to the Wt 
(Fig. 16), while the C311Y mutant exhibited a remarkably similar transcriptome to the Wt 
(Fig. 18). To the best of our knowledge, neither of these AIRE mutants has previously been 
investigated using transcriptome analysis, either with microarray or RNAseq analysis and so 
these unexpected results are difficult to judge with respect to previous literature.  
As a means to increase detection of genes with low expression in these populations, a change 
in methodology was made from the TotalRNA library preparation, which involves a step that 
removes the highly expressed ribosomal RNA, to a mRNA library preparation method using 
mRNA isolation with magnetic oligo dT beads. This approach ensures that any read in the 
sequencing is of the exome. However, neither method removes very highly expressed gene 
transcripts, such as the transfected AIRE, which in our case would be responsible for up to 
20% of reads. RNAseq using the mRNA library prep protocol was performed on the previously 
investigated RNA samples. The results were overall very similar to using the TotalRNA library 
preparation in the R257X (Fig. 19) and C311Y (Fig. 20) mutants compared to the Wt.  
In an attempt to further elucidate how stable the overall transcriptome results are between 
using two different library preparation methods, the RNAseq comparison between AIRE Wt 
and untransfected cells were redone with a new biological experiment using the mRNA 
preparation method.  (Fig. 21). This comparison yielded a very similar result, albeit with a 
general reduction of the highly differentially expressed genes compared to the previous 
experiment (Fig. 12). However, when comparing the log2 fold change and the TPM between 
the two experiments, the results were (apart from a few outliers) very similar, though with 
the log2 fold change exhibiting a general trend towards a slightly less absolute difference in 
the mRNA population compared to the initial TotalRNA sequencing (Fig. 22).  
Evaluating the replicability of RNAseq 
As a means to validate our results of the comparisons between the mutants and the Wt, new 
biologically independent experiments were performed and sequenced with an identical 
technical setup. Both the R257X (Fig. 23) and C311Y (Fig. 24) showed similar patterns as 
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previous experiments, although with a reduction in the number of highly differentially 
expressed genes. This was especially apparent in the C311Y population where only 49 genes 
were found to be significantly differentially expressed compared to AIRE Wt. However, when 
comparing the TPM and log2 fold change values across experiments, the TPM values 
correlate well between both R257X and C311Y experiments (Fig. 25). Similarly, the log2 fold 
change of the two R257X RNAseqs correlates well, but with a slight tilt towards increased 
highly differential expression in the first experiment. The log2 fold change comparison of the 
C311Y shows that there are overall low levels of significantly differentially expressed genes 
in both biological replicates, and in particular for the last RNAseq. 
Methodological optimisation 
We were not able to identify possible reporter genes using the current approach, and as 
such, it may require some methodological changes to our protocol.  
Our comparisons between the TotalRNA and mRNA library preparation methods show that 
the results are similar between the two. Although, the initial experiments for the R257X 
mutant compared with Wt suggested that mRNA (Fig. 19) preparation might yield an increase 
in the number of significantly differentially expressed genes compared to TotalRNA (Fig. 16), 
the subsequent experiment did not support that mRNA outperformed TotalRNA (Fig. 23).  
One confounder in our attempt to increase our sensitivity to lowly expressed genes is the 
extreme overexpression of AIRE in our samples. AIRE is responsible for up to 20% of all reads 
in the RNAseqs of transfected cells, or in absolute terms up to 20 million reads in a total of 
100 million reads. Thus, decreasing the amount of noncoding RNA may not have made much 
difference, as the reads would have a higher chance of populating to AIRE rather than any 
other transcript. In an attempt to properly evaluate the TPM estimates for genes between 
RNAseqs the inserted sequence from the plasmid was used to bioinformatically remove 
approximately 90% of AIRE reads in the samples before differential expression analysis. 
However, while this bioinformatical method works to reduce confounding reads in the final 
TPM estimation, it does not restore the lost sensitivity of those 20 million reads. 
Consequently, if using the same plasmid setup with extreme AIRE expression, a method to 
remove AIRE transcripts before RNAseq should be developed. One such method might be 
the use of AIRE or FLAG sequence-specific magnetic beads. Another alternative might be to 
 60
change the plasmid or promoter as a means to reduce the constitutive overexpression. One 
such alternative is the use of stably transduced cells where AIRE expression is under control 
of an inducible promoter, such as a doxycycline controlled promoter. This method has 
previously been used with success with AIRE.84 However, while this might help in finding 
relevant candidate reporter genes, a drawback with this approach is that such stable 
transduction will likely not be possible to accomplish subsequently in the high throughput 
deep mutational scanning assay.  
No transcriptome analysis has previously been done with the two mutants R257X and C311Y 
to the best of our knowledge. Thus, it is uncertain how representative these transcriptomes 
are, and how well they correspond to the physiological result of these mutations in vivo. The 
R257X mutant results in a truncated AIRE protein, which contains part of a general DNA 
interaction domain and the protein interaction domain CARD, thus it may still have some 
residual activity, consistent with our finding of a number of upregulated genes by this 
mutant. The R257X mutant may be degraded before translation in patient cells by the 
process of NMD.85 However; this process is usually only triggered when the premature stop 
codon is located at least 50-55 nucleotides upstream of an exon-exon junction, which is not 
the case in the R257X mutant.86 Notably, there are some exceptions to this rule, such as 
premature stop codons in the gene coding for the beta subunit of the T-cell receptor where 
a location 8-10 nucleotides upstream is sufficient for NMD.87 The C311Y mutant may similarly 
not represent the physiological state in patients. As evident from the western blot 
experiments this mutant is substantially degraded at the protein stage, possibly by the UPR, 
and any remaining full-length AIRE may be the result of the extreme overexpression.  
Nonetheless, these transcriptomes may be representative, yet any AIRE activity reporter 
genes might be so low in absolute transcripts that they are hard to identify using our RNAseq 
setup. This is further suggested by the fact that we were able to identify AIRE induced genes 
using qPCR that remained below the detectable limit of our RNAseq. Because AIRE activity 
has been reported to be largely stochastic, any processing of the dataset that is designed to 
remove noise may also remove any AIRE induced genes. DESeq2, used in our setup for 
differential expression analysis, makes certain assumptions about the dataset, and these 
assumptions may confound discovery of the unique transcripts of AIRE activity. Thus, it would 
have been useful to test out various analysis methods, such as baySeq differential expression 
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analysis, which does not make any assumptions about the dataset.88 Another possibility is 
the use of the chemical etoposide, in an attempt to boost AIRE activity. Etoposide prevents 
religation of the DNA strands following TOP2 cutting, leading to DSB enrichment in the 
genome. The relaxation of the chromatin may allow AIRE to work more efficiently, or the DSB 
may lead to increased DNA-PK activity and has been used in previous studies to boost the 
number of differentially expressed genes.42, 43, 84 However, etoposide does induce a large 
number of genes even without AIRE present, and so differentiating between AIRE and 
etoposide-induced genes may be difficult. In addition, our approach of using a low number 
of biological replicates and a large number of reads per sample might not have been optimal. 
It may not have increased the likelihood of discovering genes with low expression, but rather 
resulted in resequencing of the highly expressed transcripts. Instead, splitting the total 
amount of reads available amongst a greater number of biological replicates may decrease 
the noise floor and allow for identification of genes with lower differential expression. 
Indeed, such an approach has previously been evaluated and recommended.89   
Concluding remarks 
While we were able to establish an experimental system for investigation of AIRE activity, as 
confirmed by western blot, flow cytometry and qPCR, we were unable to identify any new 
AIRE inducible genes suitable as reporter genes using RNAseq. 
However, we did confirm that the previously known AIRE inducible genes KRT14 and S100A8 
have lower expression in two AIRE mutants compared to HEK293FT cells transfected with 
AIRE Wt (Fig. 11). This difference of expression in the mutants makes them possible reporter 
genes in this cell line. On the other hand, looking at the expression of these genes using 
RNAseq, the absolute expression in transcripts per million (TPM) was very low. This makes 
them challenging to use in a differential expression analysis. Pilot attempts to perform 
western blot analysis of transfected cells using KRT14 and S100A8 antibodies have thus far 
not been successful, as there was no visible band for KRT14, and only a very weakly expressed 
band for S100A8, in addition to mostly unspecific binding (data not shown).  
In addition to identifying AIRE activity reporter genes, the process of RNAseq analysis as a 
tool in such an endeavour was investigated. Comparisons of the same population with the 
same technical RNAseq setup but in different biological experiments show a good correlation 
 62
between biological experiments when it comes to absolute expression in TPM (Fig. 22b, 22c, 
25b, 25c, 25e). The absolute number of significantly differentially expressed genes and their 
log2 fold changes varies somewhat between experiments. However, the overall picture is 
very similar (Fig 22a, 25a, 25d). Comparing the different methods of RNAseq and qPCR, we 
found a highly linear correlation between the log2 of TPM in RNAseq and the reversed CT 
value from qPCR (Fig. 26) and the fold changes in both (Fig. 15). The sensitivity of a targeted 
qPCR experiment will, however, exceed the sensitivity of the more explorative transcriptome 
sequencing. Thus, AIRE reporter genes found using qPCR may not have enough reads for 
differential expression in RNAseq. 
Future perspectives 
With an inability to discover suitable reporter genes for AIRE activity, our approach to deep 
mutational scanning may need to be revised. The proposed stochastic nature of AIRE activity 
may limit the applicability of reporter genes in general, and the unspecific binding of AIRE to 
promoters of its target genes makes the development of a reporter system activated by AIRE 
challenging. It may be possible to increase the DNA binding specificity of AIRE by changing 
the SAND domain sequence. This AIRE variant may then be used as a part of a luciferase 
reporter system. However, this would be counterproductive as any mutations may then have 
a completely different effect than in the Wt sequence. Another approach is to use a proximity 
ligation assay to detect when AIRE and its partners are in proximity.90 However, this indirect 
method does not necessarily detect activity, because AIRE partners may be recruited without 
AIRE actively inducing gene transcription depending on the mutation.  
AIRE is a fascinating protein, with an extraordinary effect on the cells in which it is expressed. 
Albeit challenging, efforts to develop deep mutational scanning approaches for AIRE have 
the potential to improve APS-1 diagnostics, increase our understanding of AIREs biological 
role, and inform our knowledge of DNA repression, expression, and the nature of 
autoimmunity.   
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